ATOSSA THERAPEUTICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ATOSSA THERAPEUTICS, INC. (ATOS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$9.21 thousand for the 12-month period ending 2016-12-31, per its 10-K/A filed 2017-03-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$4.19K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$82.00.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $79.00, a 99.89% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was -$5.02K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$9.21K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$130.74K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$4.59K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$489.81K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 56 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 59 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | -$4.19K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | -$4.27K derived: sum of 2 quarters · filed 2017-03-21 | -$4.19K derived: sum of 3 quarters · filed 2017-03-21 | -$9.21K 10-K/A · filed 2017-03-21 | ||||||
| 2016-09-30 | -$82.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -$3.00 derived: sum of 2 quarters · filed 2017-03-21 | -$5.02K 10-Q/A · filed 2017-03-21 | -$68.81K derived: sum of 4 quarters · filed 2017-03-21 | ||||||
| 2016-06-30 | $79.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21 | -$4.94K 10-Q/A · filed 2017-03-21 | -$68.73K derived: sum of 3 quarters · filed 2017-03-21 | -$178.39K derived: sum of 4 quarters · filed 2017-03-21 | ||||||
| 2016-03-31 | -$5.02K 10-Q/A · filed 2017-03-21 | -$68.81K derived: sum of 2 quarters · filed 2017-03-21 | -$178.47K derived: sum of 3 quarters · filed 2017-03-21 | -$107.64K derived: sum of 4 quarters · filed 2017-03-21 | ||||||
| 2015-12-31 | -$63.79K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | -$173.45K derived: sum of 2 quarters · filed 2017-03-21 | -$102.63K derived: sum of 3 quarters · filed 2017-03-21 | -$130.74K 10-K/A · filed 2017-03-21 | ||||||
| 2015-09-30 | -$109.66K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -$38.84K derived: sum of 2 quarters · filed 2017-03-21 | -$66.95K 10-Q/A · filed 2017-03-21 | -$110.75K 10-Q · filed 2015-11-12 | $215.97K derived: sum of 4 quarters · filed 2017-03-21 | |||||
| 2015-06-30 | $70.82K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21 | $42.71K 10-Q/A · filed 2017-03-21 | -$81.67K 10-Q · filed 2015-08-06 | $325.63K derived: sum of 3 quarters · filed 2017-03-21 | $229.20K derived: sum of 4 quarters · filed 2017-03-21 | |||||
| 2015-03-31 | -$28.11K 10-Q/A · filed 2017-03-21 | -$66.03K 10-Q · filed 2015-05-13 | $254.81K derived: sum of 2 quarters · filed 2017-03-21 | $158.37K derived: sum of 3 quarters · filed 2017-03-21 | $70.27K derived: sum of 4 quarters · filed 2017-03-21 | |||||
| 2014-12-31 | $282.92K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $186.48K derived: sum of 2 quarters · filed 2016-03-30 | $98.38K derived: sum of 3 quarters · filed 2016-03-30 | -$4.59K 10-K · filed 2016-03-30 | -$343.26K 10-K · filed 2015-03-30 | |||||
| 2014-09-30 | -$96.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$184.54K derived: sum of 2 quarters · filed 2015-11-12 | -$287.51K 10-Q · filed 2015-11-12 | -$376.65K derived: sum of 4 quarters · filed 2015-11-12 | ||||||
| 2014-06-30 | -$88.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$191.07K 10-Q · filed 2015-08-06 | -$280.21K derived: sum of 3 quarters · filed 2015-08-06 | -$591.01K derived: sum of 4 quarters · filed 2015-08-06 | ||||||
| 2014-03-31 | -$102.97K 10-Q · filed 2015-05-13 | -$192.11K derived: sum of 2 quarters · filed 2015-05-13 | -$502.91K derived: sum of 3 quarters · filed 2015-05-13 | -$584.28K derived: sum of 4 quarters · filed 2015-05-13 | -$864.29K 10-Q · filed 2014-05-14 | |||||
| 2013-12-31 | -$89.14K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$399.94K derived: sum of 2 quarters · filed 2015-03-30 | -$481.31K derived: sum of 3 quarters · filed 2015-03-30 | -$489.81K 10-K · filed 2015-03-30 | -$761.33K 10-K · filed 2014-03-27 | |||||
| 2013-09-30 | -$310.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$392.17K derived: sum of 2 quarters · filed 2014-11-12 | -$400.67K 10-Q · filed 2014-11-12 | |||||||
| 2013-06-30 | -$81.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$89.87K 10-Q · filed 2014-08-12 | ||||||||
| 2013-03-31 | -$8.50K 10-Q · filed 2014-05-14 | |||||||||
| 2012-12-31 | -$134.58K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |